ARTICLE | Company News
Abbott, GlaxoSmithKline deal
July 20, 2009 7:00 AM UTC
Abbott partnered with GlaxoSmithKline to co-develop and commercialize a PCR-based companion diagnostic for GSK's MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapy) for non-small cell lung cancer (NS...